Science Explorer Back to mapMap
Discussion
Company · Courbevoie · France

Teva Pharmaceuticals (France)

Research works
6
▲ 140% vs 2018-21
Citations
86
13.9 per fractional work
Top-10% rate
4.5%
all institutions 10.0%
Open access
29%
world 40%
International
67%
world 18%

Not ranked overall: Teva Pharmaceuticals (France) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Teva Pharmaceuticals (France) work in?

In all years, 63% of research at Teva Pharmaceuticals (France) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (62%), Biochemistry, Genetics and Molecular Biology (13%), Neuroscience (10%). It does 1.5× the world's share of Health Sciences.

Health Sciences: 4 fractional works · 62.7% of its workMedicine: 4 fractional works · 62.3% of its workPulmonary and Respiratory Medicine: 1 fractional works · 15.6% of its workPhysiology: 0 fractional works · 8.1% of its workNeurology: 0 fractional works · 5.6% of its workSurgery: 0 fractional works · 5.3% of its workOncology: 0 fractional works · 4.8% of its workPsychiatry and Mental health: 0 fractional works · 4.0% of its workPathology and Forensic Medicine: 0 fractional works · 3.4% of its workEpidemiology: 0 fractional works · 2.9% of its workNephrology: 0 fractional works · 2.7% of its workGenetics: 0 fractional works · 2.1% of its workInfectious Diseases: 0 fractional works · 1.8% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.8% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.8% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.5% of its workMedical Terminology: 0 fractional works · 0.5% of its workLife Sciences: 2 fractional works · 30.0% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 12.6% of its workMolecular Biology: 1 fractional works · 9.4% of its workClinical Biochemistry: 0 fractional works · 1.8% of its workBiophysics: 0 fractional works · 0.5% of its workCancer Research: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 10.2% of its workCellular and Molecular Neuroscience: 1 fractional works · 10.2% of its workAgricultural and Biological Sciences: 0 fractional works · 2.7% of its workFood Science: 0 fractional works · 2.7% of its workImmunology and Microbiology: 0 fractional works · 2.7% of its workImmunology: 0 fractional works · 2.7% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.8% of its workToxicology: 0 fractional works · 1.8% of its workSocial Sciences: 0 fractional works · 3.7% of its workEconomics, Econometrics and Finance: 0 fractional works · 3.7% of its workEconomics and Econometrics: 0 fractional works · 3.7% of its workPhysical Sciences: 0 fractional works · 3.5% of its workPhysics and Astronomy: 0 fractional works · 1.8% of its workRadiation: 0 fractional works · 1.8% of its workChemistry: 0 fractional works · 0.8% of its workOrganic Chemistry: 0 fractional works · 0.8% of its workComputer Science: 0 fractional works · 0.5% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.5% of its workEngineering: 0 fractional works · 0.5% of its workAerospace Engineering: 0 fractional works · 0.5% of its workALL ITS WORKTevaPharmaceuticals…6fractional works, all years
Life Sciences30%Physical Sciences4%Health Sciences63%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine462.3%
    2. Health Professions00.5%
    1. Biochemistry, Genetics and Molecular Biology112.6%
    2. Neuroscience110.2%
    3. Agricultural and Biological Sciences02.7%
    4. Immunology and Microbiology02.7%
    5. Pharmacology, Toxicology and Pharmaceutics01.8%
    1. Economics, Econometrics and Finance03.7%
    1. Physics and Astronomy01.8%
    2. Chemistry00.8%
    3. Computer Science00.5%
    4. Engineering00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.08× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 15.00× its world share, 0 worksImmunology and Micro…Neuroscience: 7.98× its world share, 0 worksNeuroscienceComputer Science: 0.39× its world share, 0 worksComputer SciencePhysics and Astronomy: 4.53× its world share, 0 worksPhysics and AstronomyMedicine: 2.21× its world share, 0 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 15.0×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Immunology and Microbiology15.00×0 works
  2. Neuroscience7.98×0 works
  3. Physics and Astronomy4.53×0 works
  4. Biochemistry, Genetics and Molecular Biology3.08×0 works
  5. Medicine2.21×0 works
  6. Computer Science0.39×0 works

What are the most cited papers from Teva Pharmaceuticals (France)?

The most cited paper from Teva Pharmaceuticals (France) is "Randomized, controlled trial of rasagiline as an add‐on to dopamine agonists in Parkinson's disease" (Robert A. Hauser, Dee E. Silver, Azhar Choudhry et al., 2014), with 56 citations. Next come "Prior suggestive symptoms in one-third of patients consulting for a "first" demyelinating event" (44) and "Improved asthma control with breath-actuated pressurized metered dose inhaler (pMDI): the SYSTER survey." (32).

Most cited papers
#PaperReleasedCitations
1 Randomized, controlled trial of rasagiline as an add‐on to dopamine agonists in Parkinson's disease Robert A. Hauser, Dee E. Silver, Azhar Choudhry et al. · Movement Disorders 11 Jun 2014 56
2 Prior suggestive symptoms in one-third of patients consulting for a "first" demyelinating event Olivier Gout, Christine Lebrun‐Frénay, Pierre Labauge et al. · Journal of Neurology Neurosurgery & Psychiatry 19 Nov 2010 44
3 Improved asthma control with breath-actuated pressurized metered dose inhaler (pMDI): the SYSTER survey. Violaine Giraud, François‐André Allaert · PubMed 5 Jan 2010 32
4 Pharmacokinetics of Quinupristin/ Dalfopristin in Patients with Severe Chronic Renal Insufficiency Paul Chevalier, Jacques Rey, Oliver Pasquier et al. · Clinical Pharmacokinetics Jul 2000 15
5 Update on hydrocodone metabolites in rats and dogs aided with a semi-automatic software for metabolite identification Mass-MetaSite Austin C. Li, James P. Chovan, Erya Yu et al. · Xenobiotica 30 Aug 2012 13
All 17 most cited papers, with filters and sorting

Which research topics does Teva Pharmaceuticals (France) publish most on?

By volume in 2022-now: Immune Cell Function and Interaction, Genetic Neurodegenerative Diseases, Prostate Cancer Diagnosis and Treatment and Prostate Cancer Treatment and Research.

  1. 1 Immune Cell Function and Interaction Immunology 0 works
  2. 2 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
  3. 3 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  4. 4 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
  5. 5 Advanced Radiotherapy Techniques Radiation 0 works
  6. 6 Protein Structure and Dynamics Molecular Biology 0 works
  7. 7 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 0 works
  8. 8 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 0 works
  9. 9 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  10. 10 Data Visualization and Analytics Computer Vision and Pattern Recognition 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.4%not open70.6%

World: 40% of research is openly available.

with international co-authors66.6%domestic only33.4%

World: 18% is written across borders.

How has Teva Pharmaceuticals (France)'s research output changed?

Output in 2022-2025 was 140% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Teva Pharmaceuticals (France) as a percentage of every work published that year, 0.0000043% in 2024.

still counting0.000050%0.00010%0.00015%Teva Pharmaceuticals (France)0.0000099% in 202519801990200020102020

Fractional works of Teva Pharmaceuticals (France) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Courbevoie

All research institutions in Courbevoie

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Teva Pharmaceuticals (France). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.